This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Otten HG et al. (1993) Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis. Clin Exp Immunol 94: 236–240
Otten HG et al. (1991) Subclass distribution and size of human IgA rheumatoid factor at mucosal and nonmucosal sites. Arthritis Rheum 34: 831–839
Berglin E et al. (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of autoantibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 65: 453–458
Mikuls TR et al. (2004) Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum 50: 3776–3782
Cambridge G et al. (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48: 2146–2154
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
van Laar, J. Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?. Nat Rev Rheumatol 3, 544–545 (2007). https://doi.org/10.1038/ncprheum0596
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0596
This article is cited by
-
Clinical and diagnostic significance of serum immunoglobulin A rheumatoid factor in primary Sjogren’s syndrome
Clinical Oral Investigations (2019)